Advanced Search

Study Preview



Study Title and Description

Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
Author Cibrik D., Silva HT., Vathsala A., Lackova E., Cornu-Artis C., Walker RG., Wang Z., Zibari GB., Shihab F., Kim YS.
Country Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. dcibrik@umich.edu
Year 2013
Numbers Pubmed ID: 23422495
2136 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.